Ibuprofen and Famotidine Tablets Recalled for Foreign Tablet Contamination
Ascend Laboratories is recalling 3,288 bottles of Ibuprofen and Famotidine tablets nationwide because a stray Rasagiline Mesylate tablet was discovered in an unopened bottle during quality control.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves foreign object contamination in a prescription medication bottle. The hazard—a stray tablet of a different medication—poses a risk of harm if a consumer accidentally takes the wrong medication. No injuries have been reported.
Plain-English summary
Ascend Laboratories, LLC is recalling 3,288 bottles of Ibuprofen and Famotidine tablets (800mg/26.6mg) due to the presence of a foreign tablet. The affected bottles are distributed nationwide with lot code 23140190 and expiration date 12/31/2024.
A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle during quality control. Rasagiline Mesylate is a different medication used for Parkinson's disease. The presence of this foreign tablet could result in a consumer accidentally taking the wrong medication.
This recall was issued by the FDA and is classified as a Class II recall.
The recalled product
- Product
- IBUPROFEN AND FAMOTIDINE (IBUPROFEN AND FAMOTIDINE)
- Brand
- IBUPROFEN AND FAMOTIDINE
- Manufacturer
- Ascend Laboratories, LLC
- Affected units
- 3,288
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 23140190
- Exp. Date 12/31/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Ascend Laboratories, LLC
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- LowDabigatran Etexilate Capsules Recalled Over Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateFDA Recalls Amlodipine and Olmesartan Tablets Over Failed Dissolution Test
FDA (Drugs) · 2026-07-29
- ModerateDabigatran Etexilate Capsules Recalled Over Impurity Test Failure
FDA (Drugs) · 2026-07-29
Same hazard · foreign tablet
See all →- HighAmphetamine salt tablets recalled after bottles contained a lower strength tablet
FDA (Drugs) · 2025-09-17
- HighLisinopril and hydrochlorothiazide bottle contained a foreign antiretroviral tablet
FDA (Drugs) · 2025-07-23
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- HighMetformin ER 500 mg tablets recalled due to foreign tablet contamination
FDA (Drugs) · 2025-01-15
- ModeratePregabalin Capsules Recalled Due to Foreign Tablet Contamination During Packaging
FDA (Drugs) · 2024-06-12